Eastern Plastics Incorporation allowed to sell components produced from OXPEKK® implantable polymer

Oxford Performance Materials, Inc. (OPM) and Eastern Plastics Incorporation (EPI) have come to an agreement which enables EPI to sell machined components produced from OXPEKK® implantable polymer. OPM's OXPEKK-IG products have undergone ISO-10993 biocompatibility testing and are supported by a FDA Masterfile. This agreement allows manufacturers of implantable devices to purchase raw materials from OPM or finished machined devices directly from EPI.

“We have found that limiting device companies to the purchase of raw materials can result in burdensome supply chain costs.” said Scott DeFelice, President of OPM. “In our view many implantable device manufactures would prefer to deploy less resources on inventory and supply chain management and more on designing and developing their next generation technology. This seems to be especially true for many of the smaller developers and start-ups. This new relationship with EPI will allow our customers the flexibility to do business in a manner most consistent with their individual circumstances.”

“EPI has a superb national reputation as a company that can handle the most challenging jobs and consistently deliver. We are delighted for them to be our first approved processing partner for our implantable products”, said Mr. DeFelice. EPI will be the first of a limited number of processing partners for OXPEKK® implantable polymers, which will be located in North America, Europe and Asia. Due to the nature of implantable materials and technical requirement, OPM will limit processing partner agreements to only those firms that meet the exacting technical standards established by OPM and its ultimate customers.

“A majority of our current business is in the medical markets,” said Tom Brackett, President of EPI. “We have been actively exploring business opportunities that leverage our extensive medical machining experience and our desire to support our customers' inventory and logistics requirements. This relationship with OPM allows us to service our customers in a way that presently is not possible with implantable polyketone materials.”

For more information on implants, click here.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment